European deep tech spinouts approach US$500 billion as investment reaches record high

European deep tech spinouts approach US$500 billion as investment reaches record high

European deep tech and life sciences spinouts are worth a combined US$492 billion – having created over 220,000 jobs across more than 9,300 start-ups.

The European Spinouts Report 2026 shows investment has reached its highest level ever, with US$13.8 billion raised so far in 2026 and US$16.1 billion projected by year-end.

The report analyses European value creation and trends in spinouts, highlighting leading academic institutions, countries, sectors and founders. Now in its second edition, the report is produced by Dealroom.co together with AlbionVC, Atlantic, MITO Technology and Forward.one, and launched at Slush in Helsinki.

The University of Oxford tops this year’s European University Spinout Ranking, followed by the University of Cambridge, ETH Zurich and École Polytechnique Fédérale de Lausanne (EPFL), with the Technical University of Munich completing the top five. UK institutions hold five places in the top ten. CNRS tops the research centres ranking, followed by the Max Planck Society, CEA, INSERM and the Helmholtz Association.

At the country level, the UK leads for spinout value creation, followed by Germany, France and Switzerland. Adjusted for population, Switzerland is the clear leader, followed by Finland, Sweden, Denmark, the UK, Belgium and the Netherlands.

Value creation is accelerating, with 49% of all spinout value coming from companies founded since 2015. One hundred spinouts have reached US$100 million-plus revenues and/or a US$1 billion-plus valuation. Fourteen spinouts reached unicorn status or US$1 billion-plus exits so far this year.

European deep tech and life sciences spinouts have raised US$13.8 billion so far in 2026 and are on track to reach US$16.1 billion by year-end, a 44% increase on 2025’s previous all-time high. The largest rounds have focused on space and defence, semiconductors and quantum, nuclear fusion and life sciences.

Exit activity by value is at historical highs when excluding 2021, with US$14.8 billion so far in 2026. US acquirers have captured the majority of European spinout exit value, over US$33 billion since 2020.

At the early stage, 89% of capital comes from within Europe. However, 44% of late-stage funding still comes from outside Europe, mainly from the US. The European share of late-stage funding has risen to 56% in 2025–2026.

Deep tech has overtaken life sciences on most metrics, with a wider early-stage pipeline and more scaleups and VC funding, while life sciences narrowly leads on unicorns and enterprise value.

The authors recommend standardised spinout terms, reforming success metrics, supporting spinout growth at both ends and fostering mindset change and incentives. The average university equity stake in UK spinouts fell from 25% in 2023 to 16% in 2025. All major Danish universities adopted standard contracts in January 2026, while Germany published a national spinout framework in June.

Compared with the US since 1990, Europe has slightly more VC-backed spinouts but is two to three times behind on unicorns and funding and 13 times behind on value created. Looking only at spinouts launched since 2010, the value gap narrows to three times.

Europe now needs to convert more of its spinouts into large-scale outcomes and retain value.

Browse our latest issue

Intelligent CIO Europe

View Magazine Archive